Business Wire

SQUARE

Share
Square Announces Official Launch in Spain After Successful Early Access Programme

Square, the company specialising in software, payments, and hardware solutions for businesses of all sizes, announces its arrival in Spain following a successful Early Access Programme. Starting today, Spanish entrepreneurs, freelancers and business owners will be able to use Square's ecosystem of tools; the only end-to-end solution of its kind in the country.

"We’ve been trialing Square’s suite of products both in-store and online and we love it,” said Miguel Gil, owner of Hop Hop Hurrah , one of the first businesses to use Square’s products in Spain. “Having a point-of-sale system with integrated payments and omnichannel solutions has transformed the way we’re able to run our business, making it an easy and seamless process. We’re pleased we were able to switch to Square and feel much more confident in our ability to grow, ensuring we never miss a sale, as we look towards the future.”

Square is part of Block, Inc. a global technology company focused on financial services, founded in 2009 and headquartered in San Francisco. Square is currently present in nine countries, with Spain being the fourth European country and the first launched in 2022, after landing in Ireland and France last year and the UK in 2017. Square seeks to help entrepreneurs in a country where SMEs account for 99% of businesses, so that they can easily sell their products and services, both in physical shops and online, as their needs evolve. Square will also be rolling out support in Catalan over the coming months.

“We are thrilled to expand Square’s solutions into Spain, helping merchants to run their entire business end-to-end with integrated software, hardware and data analytics, while making it easy for them to take card payments,” said Alyssa Henry, Head of Square . “Spanish businesses of all types and sizes will now be able to use our integrated ecosystem of products and services to grow, adapt, and run their businesses.”

Xiana Méndez, Secretary of State for Trade commented: “For a quick economic recovery, SMEs and fintech industry must go hand in hand. SMEs must evolve at the same speed as the market and thanks to fintech they can do so in an easy, swift and convenient way. The technology provided by these technological financial firms guarantees them innovative solutions in terms of payment management that can be decisive in supporting their growth. In Spain, Square will find a very thriving market!”

Integrated solutions for multiple business needs

With a suite of products that fully integrate with each other, Square offers one-stop solutions for a variety of business needs: from creating an online shop, accepting physical and online card payments, or managing a retailer's inventory; to keeping a busy restaurant kitchen under control, scheduling appointments, invoicing clients, managing employees, and selling electronic gift cards, among many other time-saving services for businesses.

Square's full offer in Spain includes:

  • Point of sale and payments software and hardware to suit any business : Square launches with three point of sale (POS) software products and three versatile payment terminals, offering both mobile and brick & mortar businesses fully integrated POS software, reliable and secure payments acceptance, and one transparent processing rate. With no long-term commitments or subscription fees, the systems are designed for businesses and their employees to get started quickly.
    • Square Point of Sale is the trusted solution used by business owners around the world to process payments, sell anywhere, and manage their customer base. With fast checkout flows, built-in customer management, and intuitive sales reporting, Square Point of Sale makes it easy to run a business customers love.
  • Square for Restaurants harnesses its POS expertise with an industry-specific integrated set of tools for food and beverage merchants that would ordinarily require multiple vendors, all under one umbrella.
  • Square Appointments is an all-in-one POS for booking, payments, team management, and more. It’s built for beauty, personal care, and wellness sellers who benefit from online scheduling, automatic reminders, and payment processing to run everything easily from one place.
  • Square Register, Square Terminal, and Square Reader are versatile, easy-to-set-up devices. For a limited time, new Square sellers will be able to buy their first unit at a reduced price: Square Register will be priced at 299 € (usually 599 €), Square Terminal will be 99 € (usually 165 €), and Square Reader will be completely free (usually 19 €) – all available on Square Shop .
  • eCommerce and online payments : No matter what you sell, Square makes it easy to start selling it online.
    • Square Online is Square’s fully integrated e-commerce platform that automatically syncs inventory and orders with any Square point of sale. Square Online supports sellers across a variety of verticals: from easily enabling click-and-collect for local business, to a QR code ordering platform allowing diners to order and pay from their mobile device, to a full ecommerce website with social media integrations for retail. Square Online offers a feature-rich free plan (just pay for processing when you make a sale) as well as a variety of paid subscription plans and payment processing is competitively priced..
    • Online Checkout to quickly sell online via embeddable buy buttons and payment links.
    • Virtual Terminal to use a computer to take payments remotely.
    • Square Invoices to help businesses send professional, digital estimates and invoices and get paid faster.
    • E-Gift cards that can be sold online and in-store, to help boost sales and attract new customers.
  • Robust business tools to power operations : Square manages the behind-the-scenes details, giving time back to merchants to focus on running their business. Tools include:
    • Team Management, to streamline timecards and staffing.
    • Kitchen Display System (Square KDS), to expedite kitchen operations – including managing delivery orders.
    • App Marketplace with seamlessly integrated apps to unlock even more functionality: Square integrates with ecommerce tools like PrestaShop, WooCommerce, Wix and Ecwid, as well as accounting platforms Quaderno and CommerceSync, and ordering platforms such as Deliverect.
    • Suite of API’s enabling developers to create solutions for sellers: Our APIs and SDKs enable developers to build custom applications that can seamlessly integrate with the rest of our ecosystem of products.

An Early Access Programme with applications from a broad range of industries

The company's Early Access Programme, which started in September 2021 with limited places for beta testers, saw registrations from companies and self-employed people across multiple sectors including restaurants and hospitality, professional services, beauty, retail as well as health and wellness. Some of the Spanish establishments that have already been able to enjoy Square's services in advance are Pastelería Tallón , Valentine and Hop Hop Hurrah .

“At Square, our growth is directly tied to our customers’ growth - when they succeed, we succeed,” says Jason Lalor, European Executive Director at Square . “Our Early Access Programme has been very well received by Spanish business owners and now, with the official launch, we’re excited to partner with all types of businesses across Spain and continue to help them grow.”

Square products and services are available in Spain starting today. To learn more about getting started with Square, visit https://squareup.com/es/es

*This pricing is limited to one device per merchant. T&C’s apply.

About Square

Square helps sellers more easily run and grow their businesses with its integrated ecosystem of commerce solutions. Square offers purpose-built software to run complex restaurants and retail operations, versatile e-commerce tools, embedded financial services and banking products, an appointment booking platform, staff management and payroll capabilities, and much more – all of which work together to save sellers time and effort. Millions of sellers across the globe trust Square to power their business and help them thrive in the economy. Square is part of Block, Inc. (NYSE: SQ), a global technology company with a focus on financial services. For more information, visit www.squareup.com .

Squareup International Limited, operating under the Square brand name, is an authorised entity subject to the supervision of the Central Bank of Ireland.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release

- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye